Asthma And COPD Drugs Market
Asthma And COPD Drugs Market
The global asthma and COPD drugs market size was calculated at USD 41.04 billion in 2024, to reach USD 43.1 billion in 2025 is expected to be worth USD 66.92 billion by 2034, expanding at a CAGR of 5.01% from 2024 to 2034. The rising incidences of respiratory disorders, growing research and development, and increasing investments drive the market.
Report ID: 10008
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 41.04 Bn
Forecast Year,
USD USD 66.92 Bn
CAGR, 2025 -
5.01%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Asthma And COPD Drugs Market Size Analysis
Asthma And COPD Drugs Market Size By Diseases 2024 to 2034 (USD )
| Diseases | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asthma | 18.21 | 19.56 | 20.29 | 21.36 | 22.42 | 23.75 | 24.87 | 25.91 | 27.30 | 28.74 | 30.24 |
| COPD | 22.83 | 23.54 | 24.97 | 26.16 | 27.48 | 28.65 | 30.16 | 31.88 | 33.38 | 34.98 | 36.67 |
Asthma And COPD Drugs Market Size By Medication Class 2024 to 2034 (USD )
| Medication Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Combination Drugs | 7.69 | 8.96 | 9.27 | 9.31 | 9.59 | 10.42 | 10.63 | 11.54 | 12.07 | 12.70 | 13.36 |
| Bronchodilators | 6.34 | 6.28 | 6.53 | 6.73 | 7.47 | 7.69 | 7.95 | 8.25 | 8.61 | 9.45 | 10.33 |
| Inhaled Corticosteroids (ICS) | 4.77 | 5.11 | 5.52 | 5.75 | 5.82 | 6.31 | 6.90 | 6.87 | 7.41 | 7.88 | 7.66 |
| Short Acting Beta Agonists (SABA) | 4.54 | 4.21 | 4.53 | 4.88 | 5.10 | 5.32 | 5.38 | 6.25 | 5.78 | 5.99 | 7.01 |
| Long Acting Beta Agonists (LABA) | 4.00 | 4.46 | 4.70 | 4.82 | 4.83 | 5.24 | 5.43 | 6.31 | 6.56 | 6.67 | 6.42 |
| Leukotriene Antagonists (LTA) | 3.48 | 3.30 | 3.61 | 3.65 | 3.79 | 4.34 | 4.74 | 4.31 | 5.22 | 5.60 | 5.39 |
| Anticholinergics | 3.31 | 3.47 | 3.54 | 3.83 | 4.16 | 3.93 | 4.52 | 4.50 | 4.76 | 4.77 | 5.14 |
| Anti-Inflammatories | 4.15 | 4.57 | 4.38 | 5.03 | 5.37 | 5.52 | 5.37 | 5.92 | 5.92 | 6.67 | 7.32 |
| Others | 2.77 | 2.74 | 3.17 | 3.51 | 3.76 | 3.63 | 4.12 | 3.85 | 4.35 | 3.98 | 4.28 |
Asthma And COPD Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 14.53 | 15.13 | 16.06 | 16.75 | 17.81 | 18.73 | 19.56 | 20.57 | 20.81 | 22.18 | 23.73 |
| Retail Pharmacies | 12.24 | 12.51 | 13.38 | 14.28 | 14.85 | 15.44 | 16.37 | 17.11 | 18.48 | 19.19 | 20.23 |
| Online Pharmacies | 8.05 | 8.83 | 8.76 | 9.48 | 9.93 | 10.48 | 10.97 | 11.27 | 12.08 | 12.70 | 13.03 |
| Drug Stores | 6.23 | 6.63 | 7.06 | 7.01 | 7.31 | 7.74 | 8.14 | 8.85 | 9.30 | 9.66 | 9.93 |
Asthma And COPD Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 14.09 | 15.36 | 15.46 | 16.84 | 17.45 | 18.53 | 19.28 | 20.38 | 21.29 | 22.69 | 23.39 |
| Europe | 10.29 | 11.15 | 11.22 | 11.57 | 12.23 | 13.12 | 13.62 | 14.68 | 15.32 | 15.92 | 17.80 |
| Asia-Pacific | 7.82 | 8.54 | 9.14 | 9.41 | 9.99 | 10.50 | 11.12 | 11.39 | 12.53 | 12.50 | 13.27 |
| Latin America | 4.45 | 4.10 | 4.57 | 4.92 | 5.00 | 5.06 | 5.42 | 5.97 | 5.91 | 6.14 | 5.99 |
| Middle East & Africa | 4.39 | 3.95 | 4.87 | 4.78 | 5.22 | 5.19 | 5.58 | 5.36 | 5.63 | 6.47 | 6.46 |
Asthma And COPD Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
